Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives

  • Maria Font
  • , Antonio Monge*
  • , Elena Alvarez
  • , Ana Cuartero
  • , María José Losa
  • , María José Fidalgo
  • , Carmen Sanmartín
  • , Eva Nadal
  • , Inmaculada Ruiz
  • , Isidro Merino
  • , Juan J. Martínez-Irujo
  • , Elena Alberdi
  • , Esteban Santiago
  • , Isidro Prieto
  • , Juan J. Lasarte
  • , Pablo Sarobe
  • , Francisco Borrás
  • *Corresponding author for this work

Research output: Indexed journal article Articlepeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)305-332
Number of pages28
JournalDrug Design and Discovery
Volume14
Issue number4
Publication statusPublished - 1997
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HIV-1 RT nonnucleoside inhibitors
  • HIV-1(IIIB) HLT41acZ-1 cells
  • Quinoline
  • Quinoxaline
  • Syncytia assay

Cite this